ClinicalTrials.gg
Sign In
CompletedNCT06048419Updated Oct 7, 2026

Acceptability and Efficacy of GO MOVE

An interventional study of Home Program in Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Texas Scottish Rite Hospital for Children. Completed at 1 site in United States. Open to participants aged 3 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Texas Scottish Rite Hospital for Children · Not applicable, Interventional, and Treatment

Updated Oct 7, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Not applicable
Ages
3 Years to 17 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn about the acceptability and efficacy of Go Move, a mobile website developed to assist youth with unilateral cerebral palsy and their caregivers with setting goals and selecting exercises and activities to meet the goals. The main question[s] it aims to answer are:

  • Is Go Move accepted by youth with unilateral cerebral palsy and their caregivers?
  • Does Go Move support goal attainment for youth with unilateral cerebral palsy?

Participants will set up and participate in a goal-driven home program using the Go Move mobile website. Participants will spend 1 hour and 15 minutes per week for 6 weeks working on their home program and will complete pre-intervention and post-intervention assessments.

02

Conditions studied

  • Cerebral Palsy
  • Hemiplegic Cerebral Palsy

Browse trials for

Keywords

  • home program
03

In context

Cerebral Palsy

1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.

This study's enrollment of 9 is below the median of 34 across 1,431 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Texas Scottish Rite Hospital for Children is the lead sponsor of 18 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inclusion criteria for participants to enroll in the study include a diagnosis of unilateral CP or a non-progressive brain lesion, injury, or trauma of the developing brain that presents with a unilateral upper limb motor impairment. GMFCS levels 1 or 2. MACS levels 1-3. Age 3-17 years old, ability to follow directions, ability to complete the assessment protocol, and the ability to access the GO MOVE webpage on a personal device. All ethnic/racial groups will be eligible to participate. The ability to participate in everyday activities without restriction from a physician throughout the duration of their participation in the study (does not have restrictions/ following a medical procedure).

Exclusion criteria

Exclusion Criteria:

  • The study will exclude any patients with uncontrolled epilepsy or significant visual impairment. The study will exclude any patient with severe behavioral problems or the inability to complete the assessment protocol or home program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Go Move Home Program

    Goal driven home program

    Behavioral: Home Program

Interventions

  • BehavioralHome Program

    Home program for 6 weeks (1 hr and 15 minutes per week)

06

What researchers measure

Primary outcomes

  1. Canadian Occupational Performance Measure (COPM)

    The Canadian Occupational Performance Measure is a criterion referenced, individualized, client-centered outcome measure designed for use by occupational therapists to detect change in a client's self-perception of occupational performance over time on a scale of 1-10 (1 being the lowest)

    Time frame: within 2 weeks of start of intervention (pre-intervention), within 2 weeks of end of intervention (post-intervention)

Secondary outcomes

  1. Goal Attainment Scale (GAS) Light

    The Goal Attainment Scale is an individualized, functional outcome measure involving goal selection and scaling. The scale ranges from -2 to +2 with -2 representing a decline in function, -1 no change, 0 expected outcome, +1 a little more, +2 a lot more.

    Time frame: within 2 weeks of start of intervention (pre-intervention), within 2 weeks of end of intervention (post-intervention)

  2. Assisting Hand Assessment (AHA) (optional)

    The Assisting Hand Assessment is a criterion referenced, valid and reliable 22-item measure that assesses the assisting or affected hand in carrying out bimanual activities for children with cerebral palsy or obstetric brachial plexus palsy measured by AHA units on a scale of 0-100 with 0 being the lowest level of function.

    Time frame: within 2 weeks of start of intervention (pre-intervention), within 2 weeks of end of intervention (post-intervention)

Other outcomes

  1. Demographic information

    Demographic in formation will be collected including: age in years and months, gender, etiology of cerebral palsy, qualitative description of previous exposure to therapy

    Time frame: within 2 weeks of start of intervention (pre-intervention)

  2. Gross Motor Function Classification System (GMFCS)

    The Gross Motor Function Classification Systems is a 5-level classification system that describes the gross motor function of children and youth with cerebral palsy with 1 being the lowest functioning and 5 being the highest

    Time frame: within 2 weeks of start of intervention (pre-intervention)

  3. Manual Ability Classification Scale (MACS)

    The Manual Ability Classification Scale describes how children with cerebral palsy use their hands during activities of daily living with 1 being the least functional and 5 being the most functional

    Time frame: within 2 weeks of start of intervention (pre-intervention)

  4. Mobile App Rating Scale (MARS)

    The Moblie App Rating Scale is an objective, multidimensional tool to assess the quality of mobile health apps using likert scaling with 1 being the lowest rating and 5 being the highest

    Time frame: within 2 weeks of end of intervention (post-intervention)

  5. Feasibility and satisfaction with using the Go Move website

    A likert scale from 1-5 on the satisfaction and ease of using the Go Move website and qualitative data collection with 1 being the lowest rating and 5 being the highest

    Time frame: within 2 weeks of end of intervention (post-intervention)

07

Study locations

1 site
  • Scottish Rite for Children
    Frisco, Texas 75034, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Jul 2026, 28 months.

Of 902 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 28 months is above that.

Counting every sponsor, half of 921 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion Sep 2026 → Jul 2026 and completion Dec 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2023
First posted
Sep 21, 2023
StartActual
Feb 20, 2024
Primary completionActual
Jul 10, 2026was Sep 2026
CompletionActual
Jul 10, 2026was Dec 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 7, 2026
Primary completion
Sep 2026→Jul 10, 2026 (actual)
Oct 7, 2026
Study completion
Dec 2026→Jul 10, 2026 (actual)
Oct 7, 2026
Enrollment
50 (estimated)→9 (actual)
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Recruiting→Completed
    Primary completion Sep 2026→Jul 10, 2026 (now actual)
    Study completion Dec 2026→Jul 10, 2026 (now actual)
    Enrollment 50 (estimated)→9 (actual)
    + 4 other changes: verification date, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06048419
Lead sponsor
Texas Scottish Rite Hospital for Children
Responsible party
Angela Shierk (Clinical Scientist, Texas Scottish Rite Hospital for Children) — Principal investigator
First posted
Sep 21, 2023
Start date
Feb 20, 2024
Primary completion
Jul 10, 2026
Completion
Jul 10, 2026
Last update
Oct 7, 2026

Study contacts

Angela Shierk, PhD
principal investigator · Scottish Rite for Children

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Cerebral Palsy →

Other studies from this sponsor

Texas Scottish Rite Hospital for Children

Start the discussion